Search results
Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines | Investing.com
Investing.com· 3 days agoStocks Analysis by MarketBeat.com (Jea Yu) covering: Merck & Company Inc, Amgen Inc, Biogen Inc,...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 5 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
Gateway - Quartz
Quartz· 2 days agoModerna stock rose after new data suggested that its experimental vaccine could be used to treat a variety of cancers. The American Society of Health-System ...
Gateway - Quartz
Quartz· 2 days agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an early-phase clinical trial testing the combined use of an ...
Oppenheimer Increases Moderna (NASDAQ:MRNA) Price Target to $179.00
ETF DAILY NEWS· 6 days agoOppenheimer’s price objective would suggest a potential upside of 23.25% from the stock’s current price. Royal Bank of Canada increased their price objective on shares of ...
Moderna (NASDAQ:MRNA) shareholders are still up 857% over 5 years despite pulling back 6.1% in the...
Simply Wall St. via Yahoo Finance· 6 days agoThat's well above most pre-profit companies. Arguably, this is well and truly reflected in the...
Gerber LLC Purchases New Stake in Lowe’s Companies, Inc. (NYSE:LOW)
ETF DAILY NEWS· 3 days agoReport) in the 4th quarter, according to the company in its most recent Form 13F filing with the...
Gateway - Quartz
Quartz· 1 day agoNovo Nordisk responded this week to the Federal Trade Commission’s (FTC) suggestion that it filed ‘junk’ patents to prevent competition and raise prices. Moderna ...
Gateway - Quartz
Quartz· 1 day agoNovo Nordisk and Johnson & Johnson both announced billion-dollar deals to acquire heart treatments. Walgreens Boots Alliance stock fell slightly in pre-market trading Thursday ...
Moderna says new-generation COVID vaccine more effective than Spikevax
Market Watch· 7 days ago“Today’s vaccine efficacy data are consistent with the previously announced immunogenicity results...
